Imagine being born with a condition so rare, most doctors only read about it in textbooks. That’s the reality for patients with Alagille Syndrome, a genetic disorder that affects the liver, heart, and other vital organs. While once overlooked, this rare disease is finally gaining global attention—and so is the growing effort to treat it. In a major shift, pharmaceutical companies...